May 2, 2022 – Johnson & Johnson MedTech have announced that Biosense Webster, Inc., a worldwide leader in the science and technology of cardiac arrhythmia treatment, enrolled the first patients in its ...
EP Mapping and Imaging Systems
This channel page contains news on new technology innovations for electrophysiology (EP) mapping and imaging systems used to guide transcatheter cardiac ablation procedures. These systems use mapping catheters that contain electrodes that measure the electrical activity of the cardiac tissue. This is transferred into mapping system software where a 3D model is created of the heart, a color-coded overlay showing the electrical waves generated during each heart beat, the touch points where the tissue was mapped, and showing the location of the catheter inside the heart. Tissue identified as having unhealthy electrical activity that is cause an arrhythmia can then be ablated directly or isolated using an ablation catheter to cause small burns/scar tissue that block electrical signals.
December 14, 2022 — Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of ...
May 2, 2022 – Johnson & Johnson MedTech have announced that Biosense Webster, Inc., a worldwide leader in the science ...
April 29, 2022 – Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” ...
April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...
March 3, 2022 – CIRCA Scientific, Inc. has announced that its S-CATH M Esophageal Temperature Probe is now cleared for ...
January 14, 2022 — Medtronic has entered into a definitive agreement to acquire Affera Inc., a Boston area-based ...
January 13, 2022 — Abbott received U.S. Food and Drug Administration (FDA) clearance for the EnSite X EP System with ...
November 22, 2021 — BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical ...
November 16, 2021 — Acutus Medical Inc. (Acutus), an arrhythmia management company focused on improving the way cardiac ...
November 15, 2021 — Vektor Medical Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...
October 28, 2021 — CathVision, a medical technology company developing electrophysiology (EP) solutions in EP recording ...
An example of the Acutus Medical AcQMap High Resolution Imaging and Mapping System to guide electrophysiology (EP) cardi ...
September 1, 2021 — Stereotaxis and Shanghai Microport EP Medtech Co., Ltd. announced a broad collaboration to advance ...
August 3, 2021 – Biosense Webster, the global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
Jass Brooks, vice president of global strategic marketing, Biosense Webster, explains four over-arching electrophysiolog ...